157 related articles for article (PubMed ID: 28587251)
1. Pharmacokinetics and Tissue Distribution Kinetics of Puerarin in Rats Using Indirect Competitive ELISA.
Kong H; Wang X; Shi R; Zhao Y; Cheng J; Yan X; Liu X; Wang Y; Zhang M; Wang Q; Qu H
Molecules; 2017 Jun; 22(6):. PubMed ID: 28587251
[TBL] [Abstract][Full Text] [Related]
2. Distribution kinetics of puerarin in rat hippocampus after acute local cerebral ischemia.
Kong H; Zhang G; Cheng J; Shi R; Zhang M; Cao P; Zhao Y; Qu H; Wang Q
J Pharm Biomed Anal; 2019 Feb; 164():196-201. PubMed ID: 30390562
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration.
Luo CF; Yuan M; Chen MS; Liu SM; Zhu L; Huang BY; Liu XW; Xiong W
Int J Pharm; 2011 May; 410(1-2):138-44. PubMed ID: 21392565
[TBL] [Abstract][Full Text] [Related]
4. Effect of Puerarin on the Pharmacokinetics of Baicalin in Gegen Qinlian Decoction () in Mice.
Kong H; Wang XQ; Wang QG; Zhao Y; Sun Y; Zhang Y; Xu JK; Qu HH
Chin J Integr Med; 2018 Jul; 24(7):525-530. PubMed ID: 25908218
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic, tissue distribution, and excretion of puerarin and puerarin-phospholipid complex in rats.
Li Y; Pan WS; Chen SL; Xu HX; Yang DJ; Chan AS
Drug Dev Ind Pharm; 2006 Apr; 32(4):413-22. PubMed ID: 16638679
[TBL] [Abstract][Full Text] [Related]
6. Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile.
Li W; Wu J; Zhang J; Wang J; Xiang D; Luo S; Li J; Liu X
Drug Deliv; 2018 Nov; 25(1):827-837. PubMed ID: 29587545
[TBL] [Abstract][Full Text] [Related]
7. [Effect of phenformin hydrochloride on pharmacokinetics of puerarin in rats].
Deng Y; Li N; Cui M; Xiong ZL; Li FM
Zhongguo Zhong Yao Za Zhi; 2012 Oct; 37(19):2960-3. PubMed ID: 23270242
[TBL] [Abstract][Full Text] [Related]
8. Formulation optimization and bioavailability after oral and nasal administration in rabbits of puerarin-loaded microemulsion.
Yu A; Wang H; Wang J; Cao F; Gao Y; Cui J; Zhai G
J Pharm Sci; 2011 Mar; 100(3):933-41. PubMed ID: 20862776
[TBL] [Abstract][Full Text] [Related]
9. A New Highly Selective and Specific Anti-puerarin polyclonal Antibody for Determination of Puerarin Using a Mannich Reaction Hapten Conjugate.
Udomsin O; Krittanai S; Kitisripanya T; Tanaka H; Putalun W
Pharmacogn Mag; 2018 Jan; 13(Suppl 4):S845-S851. PubMed ID: 29491643
[TBL] [Abstract][Full Text] [Related]
10. RGD modified and PEGylated lipid nanoparticles loaded with puerarin: Formulation, characterization and protective effects on acute myocardial ischemia model.
Dong Z; Guo J; Xing X; Zhang X; Du Y; Lu Q
Biomed Pharmacother; 2017 May; 89():297-304. PubMed ID: 28236703
[TBL] [Abstract][Full Text] [Related]
11. A HPLC-UV method for the determination of puerarin in rat plasma after intravenous administration of PEGylated puerarin conjugate.
Liu X; Zhi H; Du F; Ye Z; Wang N; Qin W; Li J
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(31):3297-302. PubMed ID: 21056017
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetics, pharmacodynamics, and tissue distribution of oral co-loaded puerarin/daidzein mixed micelles in rats].
Wu WT; Guo ZL; Ge SC; Kuang WL; Li WD; Wang SD; Liu P; Zhou ZW; Zhu WF
Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):5068-5077. PubMed ID: 37802849
[TBL] [Abstract][Full Text] [Related]
13. N-trimethyl chitosan (TMC)-modified microemulsions for improved oral bioavailability of puerarin: preparation and evaluation.
Liao D; Liu X; Dai W; Tang T; Ou G; Zhang K; Han M; Kang R; Yang S; Xiang D
Drug Deliv; 2015; 22(4):516-21. PubMed ID: 24467620
[TBL] [Abstract][Full Text] [Related]
14. In Vivo Pharmacokinetics of Puerarin via Different Drug Administration Routes Based on Middle Cerebral Artery Occlusion Model.
Li P; Bai J; Dong B; Lu Y; Zhang S; Guo S; Tan N; Zhao M; Du S; Cao P
Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):719-727. PubMed ID: 27928655
[TBL] [Abstract][Full Text] [Related]
15. Absolute oral bioavailability and disposition kinetics of puerarin in female rats.
Anukunwithaya T; Poo P; Hunsakunachai N; Rodsiri R; Malaivijitnond S; Khemawoot P
BMC Pharmacol Toxicol; 2018 May; 19(1):25. PubMed ID: 29801513
[TBL] [Abstract][Full Text] [Related]
16. Formulation optimization of self-emulsifying preparations of puerarin through self-emulsifying performances evaluation in vitro and pharmacokinetic studies in vivo.
Quan DQ; Xu GX
Yao Xue Xue Bao; 2007 Aug; 42(8):886-91. PubMed ID: 17944241
[TBL] [Abstract][Full Text] [Related]
17. A study on puerarin in situ gel eye drops: Formulation optimization and pharmacokinetics on rabbits by microdialysis.
Jin L; Li X; Chen X; Chen X; Liu Y; Xu H; Wang Q; Tang Z
Int J Pharm; 2023 Jul; 642():123176. PubMed ID: 37364779
[TBL] [Abstract][Full Text] [Related]
18. Tissue distribution of puerarin and its conjugated metabolites in rats assessed by liquid chromatography-tandem mass spectrometry.
Prasain JK; Peng N; Moore R; Arabshahi A; Barnes S; Wyss JM
Phytomedicine; 2009 Jan; 16(1):65-71. PubMed ID: 19027277
[TBL] [Abstract][Full Text] [Related]
19. Role of puerarin in the signalling of neuropathic pain mediated by P2X3 receptor of dorsal root ganglion neurons.
Xu C; Xu W; Xu H; Xiong W; Gao Y; Li G; Liu S; Xie J; Tu G; Peng H; Qiu S; Liang S
Brain Res Bull; 2012 Jan; 87(1):37-43. PubMed ID: 22044944
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization, and pharmacokinetic evaluation of puerarin submicron emulsion.
Yue PF; Yuan HL; Yang M; You RH; Cong LB; Zhu J; Wang Q; Zhu WF; Xiao XH
PDA J Pharm Sci Technol; 2008; 62(1):32-45. PubMed ID: 18402366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
